USPSTF one-time abdominal ultrasound in men aged 65–75 who have ever smoked; elective repair (EVAR or open) at >=5.5 cm in men (>=5.0 cm in women) or growth >0.5 cm/6 months.
Type A involves ascending aorta -> emergency surgical repair; Type B involves only descending aorta (distal to left subclavian) -> IV esmolol/labetalol first, then nicardipine/nitroprusside.
Normal 0.91–1.30; Intermittent claudication 0.41–0.90 (first-line treatment is supervised graded exercise + cilostazol + statin/antiplatelet); Critical limb ischemia <=0.40 (rest pain/ulcers).
Pain, Pallor, Pulselessness, Poikilothermia, Paresthesia (early nerve ischemia), Paralysis (late irreversible ischemia); start IV unfractionated heparin immediately and perform embolectomy.
Palpable breast mass in woman <30 yr = Ultrasound first; Woman >=30 yr = Diagnostic Mammogram + Ultrasound; BI-RADS 4 or 5 requires Core Needle Biopsy.
Long thoracic nerve -> winged scapula (serratus anterior); Thoracodorsal nerve -> weak arm adduction/internal rotation (latissimus dorsi); Intercostobrachial -> medial arm numbness.
Measure serum TSH + thyroid ultrasound first; Low TSH (hot nodule) -> Radionuclide I-123 scan; Normal/High TSH + suspicious US (>=1 cm, microcalcifications) -> Fine-Needle Aspiration (FNA).
Expanding neck hematoma -> open bedside sutures immediately; Recurrent laryngeal nerve injury -> hoarseness (unilateral) or airway obstruction (bilateral); Parathyroid stun -> hypocalcemia.
Abdominal Aortic Aneurysm (AAA), Stanford A/B Dissection & Carotid Endarterectomy
Abdominal Aortic Aneurysms (AAAs) are most commonly located infrarenally (below the renal arteries) and result from atherosclerosis, transmural matrix metalloproteinase degradation of medial elastin and collagen, and Loss of vasa vasorum perfusion. Smoking is the #1 modifiable risk factor for AAA development, expansion, and rupture. The USPSTF recommends a one-time screening abdominal duplex ultrasound for men aged 65–75 years who have ever smoked (≥100 lifetime cigarettes). Asymptomatic AAAs are monitored with serial ultrasound (every 3 years for 3.0–3.9 cm; every 12 months for 4.0–4.9 cm; every 6 months for 5.0–5.4 cm), and elective surgical repair via Endovascular Aneurysm Repair (EVAR) or open graft is indicated when diameter reaches ≥5.5 cm in men (≥5.0 cm in women), expansion rate exceeds >0.5 cm in 6 months (>1.0 cm/year), or the aneurysm becomes symptomatic (abdominal/back tenderness).
Ruptured AAA presents with the classic triad of sudden severe tearing abdominal/flank/back pain, a pulsatile abdominal mass, and hypotensive shock (often rupturing into the retroperitoneum, where hematoma tamponade may transiently stabilize blood pressure, or eroded into the duodenum as an aortoenteric fistula after prior graft repair).
| Vascular Condition | Anatomical Definition / Threshold | First-Line Diagnostic Modality | Definitive Medical / Surgical Management | Classic Post-Operative Complication |
|---|---|---|---|---|
| Abdominal Aortic Aneurysm (AAA) | Infrarenal aortic diameter >=3.0 cm; Repair at >=5.5 cm (men), >=5.0 cm (women), or >0.5 cm/6 mo | Screening/Surveillance: Duplex Ultrasound | Pre-op/Stable Rupture: CT Angiography | Unstable Rupture: Immediate OR | Smoking cessation; Elective EVAR or open graft; Unstable rupture -> Immediate OR with permissive hypotension | Ischemic colitis of sigmoid colon (IMA occlusion -> bloody diarrhea, confirm with sigmoidoscopy) & Adamkiewicz spinal cord ischemia |
| Stanford Type A vs. Type B Dissection | Type A: Involves Ascending Aorta | Type B: Descending Aorta ONLY (distal to left subclavian) | Stable: CT Angiography (CTA) of chest/abdomen | Unstable / Renal failure: Transesophageal Echo (TEE) | Type A: Immediate open surgical graft | Uncomplicated Type B: IV Esmolol/Labetalol FIRST (HR <60, SBP <120), then Nicardipine/Nitroprusside | Never give hydralazine or nitroprusside alone before beta-blockade (reflex tachycardia increases aortic wall shear stress dP/dt) |
| Carotid Artery Stenosis | Symptomatic TIA/stroke vs. Asymptomatic bifurcation plaque | Carotid Duplex Ultrasound (confirm with CTA or MRA neck) | Medical therapy (Aspirin + high-intensity Statin) for all + Carotid Endarterectomy (CEA) for Symptomatic 70–99% (or 50–69% in men) | CN XII (hypoglossal) injury -> tongue deviates ipsilateral to surgery; never operate on 100% occluded carotid artery |
| Subclavian Steal Syndrome | Proximal subclavian artery stenosis proximal to vertebral artery origin | Duplex ultrasound showing retrograde flow in ipsilateral vertebral artery + CTA arch | Endovascular subclavian angioplasty/stenting or carotid-subclavian bypass | Arm exercise reproduces posterior circulation symptoms (vertigo, ataxia, syncope) with >15 mmHg lower BP in affected arm |
| Thoracic Outlet Syndrome (TOS) | Compression between anterior and middle scalenes / cervical rib / 1st rib | Neurogenic (95%: C8–T1 brachial plexus) vs. Venous (Paget-Schroetter effort thrombosis) vs. Arterial | Neurogenic: Physical therapy & OMT | Venous/Arterial: Catheter thrombolysis + surgical 1st rib & anterior scalene resection | Adson test, Roos elevated arm stress test, and cervical radiograph for congenital C7 cervical rib |
Ruptured AAA Management, Post-EVAR Endoleaks & Ischemic Colitis
In suspected ruptured AAA: if the patient is hemodynamically unstable, confirm with bedside ultrasound if needed and proceed immediately to the operating room for emergency EVAR or open aortic clamping with permissive hypotension (SBP 70–90 mmHg; never send an unstable ruptured AAA to the CT scanner!). If the patient is hemodynamically stable with suspected rupture, perform an urgent CT angiogram (CTA) of the abdomen/pelvis to define neck anatomy for EVAR. Following open or endovascular AAA repair, two critical surgical complications are tested on boards: (1) Left-sided ischemic colitis presenting on POD 1–3 with bloody diarrhea, fever, leukocytosis, and lactic acidosis due to intraoperative ligation/occlusion of the inferior mesenteric artery (IMA) when collateral flow via the marginal artery of Drummond is inadequate (confirm with bedside flexible sigmoidoscopy showing dusky/cyanotic mucosa at the splenic flexure/sigmoid colon), and (2) Anterior spinal cord syndrome (paraplegia with loss of pain/temperature and preserved dorsal column vibration/proprioception) due to occlusion of the artery of Adamkiewicz (arising at T8–L2). In Aortic Dissection (intimal tear propagating blood into a false lumen within the tunica media, driven by hypertension or Marfan cystic medial necrosis), Stanford Type A (any involvement of the ascending aorta) is a surgical emergency requiring immediate open surgical repair due to risk of pericardial tamponade, acute aortic regurgitation, and right coronary artery occlusion, whereas uncomplicated Stanford Type B (restricted to the descending thoracic aorta distal to the left subclavian artery) is managed medically with intravenous beta-blockers first (esmolol or labetalol) to reduce dP/dt shear stress (target HR <60 bpm, SBP 100–120 mmHg), followed by vasodilators (nicardipine or sodium nitroprusside) only after beta-blockade is established.
Carotid Artery Stenosis, Subclavian Steal Syndrome & Thoracic Outlet Syndrome
Extracranial internal carotid artery atherosclerosis at the carotid bifurcation causes transient ischemic attacks (amaurosis fugax—ipsilateral painless “curtain coming down” monocular vision loss with cholesterol Hollenhorst plaques on fundoscopy—or contralateral hemiparesis/aphasia) and ischemic strokes. Carotid Endarterectomy (CEA) (plus lifelong aspirin, high-intensity statin, and smoking cessation) is indicated for symptomatic carotid stenosis of 70–99% (and 50–69% in men with low surgical risk; performed within 2 weeks of the index TIA/minor stroke) and selected asymptomatic stenosis of 70–99%; cranial nerve injuries during CEA include the hypoglossal nerve (CN XII: tongue deviates toward the side of the surgery), marginal mandibular branch of CN VII (asymmetric smile/droop), and vagus/recurrent laryngeal nerve (hoarseness). Complete occlusion (100% stenosis) is never operated on. Subclavian Steal Syndrome results from proximal subclavian artery stenosis proximal to the origin of the vertebral artery; exercising the ipsilateral arm lowers arm vascular resistance and reverses blood flow (retrograde) down the ipsilateral vertebral artery from the basilar artery, precipitating vertebrobasilar insufficiency (vertigo, syncope, ataxia, diplopia) and a >15 mmHg systolic blood pressure discrepancy between the arms.
Peripheral Arterial Disease (ABI), Acute Limb Ischemia (6 P's) & Chronic Venous Insufficiency
Lower Extremity Peripheral Arterial Disease (PAD) reflects atherosclerotic narrowing of the aortoiliac, femoropopliteal (most commonly the superficial femoral artery in the adductor canal), or tibial arteries, strongly associated with smoking, diabetes mellitus, hypertension, and hyperlipidemia. Clinical severity progresses from asymptomatic disease to reproducible exertional calf/buttock cramping relieved within 10 minutes of rest (intermittent claudication; note that aortoiliac occlusion causes Leriche syndrome: buttock/thigh claudication, absent femoral pulses, and erectile dysfunction), and ultimately to critical limb-threatening ischemia (CLI)—defined by ischemic rest pain in the forefoot/toes (worse at night when supine, relieved by hanging the foot over the side of the bed) and non-healing punched-out arterial ulcers on the distal toes or lateral malleolus.
The initial non-invasive diagnostic test for PAD is the resting Ankle-Brachial Index (ABI) (ratio of highest ankle dorsalis pedis/posterior tibial systolic pressure to highest brachial artery systolic pressure).
| Vascular Disorder | ABI / Diagnostic Signature | Characteristic Ulcer / Physical Findings | First-Line Medical Therapy | Definitive Surgical / Procedural Intervention |
|---|---|---|---|---|
| Intermittent Claudication (PAD) | ABI 0.41–0.90 (or TBI <0.70 if ABI >1.30 calcified in diabetes/ESRD) | Reproducible calf/thigh/buttock pain with walking, relieved within 10 min of rest; shiny hairless skin | Smoking cessation + High-intensity Statin + Aspirin/Clopidogrel + Supervised Exercise + Cilostazol (avoid in CHF) | Revascularization only if lifestyle-limiting symptoms persist despite 3–6 months of supervised exercise & cilostazol |
| Critical Limb Ischemia (CLI) | ABI <=0.40 (ankle systolic pressure <50 mmHg, toe pressure <30 mmHg) | Ischemic rest pain in forefoot (relieved by dangling leg), dry gangrene, deep 'punched-out' distal toe/lateral malleolus ulcers | Antiplatelet, statin, wound care (NEVER apply tight compression stockings to an ischemic limb) | Urgent CT/MR/catheter angiography and surgical bypass (autogenous great saphenous vein) or endovascular angioplasty |
| Acute Limb Ischemia (ALI) | Sudden loss of arterial Doppler signal; 6 P's (Pain, Pallor, Pulselessness, Poikilothermia, Paresthesia, Paralysis) | Sudden cold, mottled, pulseless leg in patient with Atrial Fibrillation or recent MI | IMMEDIATE IV Unfractionated Heparin bolus & infusion (before imaging or transport to OR) | Viable/Marginally threatened (Rutherford I/II): Urgent surgical embolectomy or thrombolysis + prophylactic fasciotomy | Irreversible rigor (III): Amputation |
| Leriche Syndrome (Aortoiliac PAD) | Bilateral decreased ABI with absent/diminished femoral pulses | Classic Triad: Bilateral buttock/thigh claudication + Erectile dysfunction (impotence) + Absent femoral pulses | Smoking cessation, statin, antiplatelet, exercise | Aortobifemoral bypass grafting or endovascular iliac Kissing stents |
| Chronic Venous Insufficiency vs. Neuropathic Ulcer | CVI: Normal ABI (>=0.9), venous duplex reflux | Neuropathic: Loss of 10-g monofilament sensation | CVI: Shallow weeping ulcer at MEDIAL MALLEOLUS + hemosiderin | Diabetic Neuropathic: Painless plantar ulcer over metatarsal heads | CVI: Leg elevation + Compression stockings/Unna boot | Neuropathic: Total contact casting (pressure offloading) + debridement | Probe-to-bone test or MRI diagnoses underlying osteomyelitis in diabetic foot ulcers |
ABI Interpretation, Supervised Exercise, Cilostazol & Revascularization
An ABI of 0.91–1.30 is normal; 0.41–0.90 indicates mild-to-moderate PAD (intermittent claudication); ≤0.40 indicates severe PAD / critical limb ischemia (rest pain and gangrene risk); and >1.30 indicates non-compressible calcified vessels (Monckeberg medial calcific sclerosis in patients with diabetes mellitus or end-stage renal disease, requiring a Toe-Brachial Index [TBI <0.70 abnormal] or pulse volume recordings). All PAD patients require aggressive cardiovascular risk reduction (smoking cessation, high-intensity statin, antiplatelet therapy with aspirin or clopidogrel, and blood pressure/glycemic control). For stable intermittent claudication, the #1 most effective first-line therapy is a supervised graded walking exercise program (30–45 minutes, ≥3 times/week for ≥12 weeks, walking to near-maximal claudication pain before resting), paired with the phosphodiesterase-3 (PDE-3) inhibitor cilostazol (which inhibits platelet aggregation and vasodilates arteries; strictly contraindicated in heart failure of any severity). Surgical or endovascular revascularization (angioplasty/stenting or femoral-popliteal bypass using reversed great saphenous vein) is reserved for lifestyle-limiting claudication refractory to 3–6 months of medical/exercise therapy or any patient with critical limb ischemia (ABI ≤0.40, rest pain, or non-healing ischemic ulcers).
Acute Limb Ischemia (The 6 P's) vs. Chronic Venous Insufficiency Ulcers
Acute Limb Ischemia (ALI) is a sudden, limb-threatening arterial occlusion caused most commonly by cardiogenic embolism (atrial fibrillation or post-MI left ventricular mural thrombus lodging at the common femoral or popliteal artery bifurcation) or acute thrombosis of a pre-existing atherosclerotic plaque/bypass graft, presenting with the 6 P's: Pain, Pallor, Pulselessness, Poikilothermia (cool extremity), Paresthesia (early sign of sensory nerve ischemia), and Paralysis (late sign of motor ischemia). The very first step in management upon clinical suspicion of ALI is immediate intravenous unfractionated heparin anticoagulation (to prevent proximal/distal thrombus propagation), followed by urgent Fogarty catheter embolectomy, catheter-directed thrombolysis, or surgical bypass within 6 hours; after revascularization of a prolonged ischemic limb, monitor closely for lower-leg compartment syndrome requiring four-compartment fasciotomy. In contrast to punched-out distal arterial ulcers, Chronic Venous Insufficiency (CVI) (from deep/superficial venous valve incompetence after DVT) presents with aching leg heaviness worse with prolonged standing, pitting edema, brownish hemosiderin stasis hyperpigmentation, lipodermatosclerosis, and shallow, exudative, irregular ulcers over the medial malleolus (gaiter area); first-line treatment is leg elevation and graduated compression stockings / Unna boot therapy (after verifying ABI ≥0.8 to ensure compression does not worsen arterial ischemia).
Breast Mass Diagnostic Algorithms, BI-RADS (0–6) & Benign Breast Pathology
Evaluation of a palpable breast mass or nipple discharge follows a strict age- and imaging-stratified surgical algorithm. Because young women have dense fibroglandular breast tissue that obscures mammographic detail, the initial imaging modality for a palpable breast mass in a woman under age 30 is a targeted breast ultrasound, whereas in a woman aged 30 or older, the initial workup is a diagnostic mammogram paired with targeted breast ultrasound. Crucially, a normal mammogram and ultrasound never rule out malignancy if a clinically suspicious, firm, fixed palpable mass is present on physical examination—any suspicious palpable mass requires tissue diagnosis via ultrasound-guided core needle biopsy.
Mammographic reports are standardized using the Breast Imaging Reporting and Data System (BI-RADS 0–6), which dictates the exact next clinical step.
| Breast Entity / BI-RADS | Age & Clinical Presentation | Imaging & Histopathology | Malignant Potential | Definitive Next Step in Management |
|---|---|---|---|---|
| Fibroadenoma vs. Phyllodes Tumor | Fibroadenoma: <30 yr, rubbery mobile mass | Phyllodes: 40–50 yr, rapidly growing large mass | Fibroadenoma: Oval wider-than-tall mass | Phyllodes: Leaf-like cellular stromal clefts on core biopsy | Fibroadenoma: Benign | Phyllodes: Benign, borderline, or malignant sarcoma (hematogenous lung spread) | Fibroadenoma: Observe (excise if >3 cm) | Phyllodes: Wide local excision with >=1 cm margins (NO axillary lymphadenectomy) |
| Simple Breast Cyst vs. Complex Cyst | 30–50 yr premenopausal woman with cyclic tender mass | Ultrasound: Simple = anechoic, posterior acoustic enhancement | Complex = thick septations/solid mural component | Simple cyst: 0% malignant | Complex cyst: 15–20% malignant | Simple cyst: Reassurance (aspirate only if painful; biopsy if bloody fluid or recurs) | Complex mass: Core needle biopsy |
| Intraductal Papilloma | Unilateral, spontaneous, single-duct bloody or serous nipple discharge without a palpable mass | Subareolar ductal dilation on US/ductogram; fibrovascular cores lined by BOTH epithelial and myoepithelial cells | Benign (unless atypical hyperplasia/DCIS is present in specimen) | Diagnostic mammogram + ultrasound followed by surgical single-duct excision (microdochectomy) |
| Fat Necrosis of the Breast | History of seatbelt trauma, fall, or prior breast reduction/biopsy | Spiculated mass with calcified oil cysts on mammogram; biopsy shows foamy macrophages & giant cells | 0% malignant (important benign clinical and radiographic mimic of invasive carcinoma) | Confirm diagnosis with core needle biopsy to exclude malignancy, then reassurance |
| BI-RADS 0, 3, 4 & 5 | Screening or diagnostic mammography classification | BI-RADS 0: Incomplete | 3: Probably benign | 4: Suspicious | 5: Highly suggestive of malignancy (spiculated) | BI-RADS 3: <2% | BI-RADS 4: 2–95% | BI-RADS 5: >=95% | BI-RADS 0: Additional views/US | BI-RADS 3: Repeat mammogram in 6 months | BI-RADS 4 & 5: Core Needle Biopsy |
BI-RADS Categories 0–6 & Nipple Discharge Evaluation (Intraductal Papilloma vs. Galactorrhea)
BI-RADS 0 (Incomplete): requires additional imaging views (spot compression/magnification) or comparison with prior films. BI-RADS 1 (Negative) and BI-RADS 2 (Benign—e.g., calcified fibroadenoma, simple cyst, intramammary lymph node): resume routine screening mammography. BI-RADS 3 (Probably Benign, <2% malignancy risk): repeat short-interval diagnostic follow-up imaging in 6 months. BI-RADS 4 (Suspicious abnormality, 2–95% risk—e.g., pleomorphic microcalcifications) and BI-RADS 5 (Highly suggestive of malignancy, ≥95% risk—e.g., spiculated mass with linear branching microcalcifications): mandate immediate image-guided Core Needle Biopsy (CNB) (superior to fine-needle aspiration because CNB distinguishes invasive carcinoma from DCIS and allows ER/PR/HER2 receptor staining). BI-RADS 6: biopsy-proven malignancy awaiting definitive surgical therapy. For nipple discharge: bilateral, multi-duct, milky discharge (galactorrhea) is benign/endocrine—always order a pregnancy test (beta-hCG), serum prolactin, and TSH (primary hypothyroidism elevates TRH, which stimulates lactotrophs to secrete prolactin!). Conversely, unilateral, single-duct, spontaneous bloody or serosanguinous nipple discharge is pathologic: the #1 most common cause is a benign intraductal papilloma (a small subareolar fibrovascular polyp lined by both luminal epithelial and outer p63/calponin-positive myoepithelial cells), but underlying ductal carcinoma must be excluded via diagnostic mammogram/ultrasound and surgical microdochectomy (single-duct excision).
Benign Breast Lesions: Fibroadenoma, Phyllodes Tumor, Fibrocystic Change, Fat Necrosis & Mastitis
Fibroadenoma is the most common benign breast tumor in women under age 30, presenting as a discrete, firm, rubbery, well-circumscribed, freely mobile (“breast mouse”) mass that enlarges with estrogen surges (pregnancy/menses); ultrasound shows a smooth, wider-than-tall oval mass, managed conservatively with reassurance and serial ultrasound (or surgical enucleation if >2–3 cm or growing). Phyllodes tumor is a fibroepithelial tumor typically presenting in women aged 40–50 as a rapidly enlarging breast mass with classic leaf-like stromal projections on histology and variable malignant potential (sarcomatous overgrowth spreads hematogenously to the lungs, not via axillary lymph nodes); treatment is wide local excision with ≥1 cm negative surgical margins (without axillary node dissection). Fibrocystic changes present in premenopausal women with cyclic bilateral breast nodularity and premenstrual mastodynia; simple fluid-filled cysts on ultrasound require aspiration only if symptomatic (discard clear/green fluid; send for cytology and biopsy only if the cyst aspirate is grossly bloody or a residual mass persists after aspiration). Fat necrosis follows blunt breast trauma (seatbelt injury) or prior breast surgery, presenting as a firm, irregular mass with skin retraction and dystrophic calcifications on mammogram that closely mimic carcinoma (biopsy shows lipid-laden foamy macrophages and multinucleated giant cells with saponification). Lactational mastitis (Staphylococcus aureus entering via nipple fissures during weeks 2–6 of breastfeeding) presents with a focal erythematous wedge-shaped tender area and fever; treat with dicloxacillin or cephalexin PLUS continued frequent breastfeeding/pumping (if a fluctuant breast abscess is present on ultrasound, perform needle aspiration or incision and drainage while continuing to express milk).
Breast Cancer Pathology (DCIS, IDC, ILC, Paget, Inflammatory) & Surgical Staging
Breast carcinoma is the most common non-cutaneous malignancy in women and the #2 cause of cancer mortality in women (after lung cancer). Risk increases with cumulative lifetime estrogen exposure (early menarche, late menopause, nulliparity, late first pregnancy, hormone replacement therapy, obesity), advanced age, ionizing chest radiation, and germline mutations in BRCA1 (Chr 17; associated with high-grade triple-negative breast cancer and serous ovarian carcinoma), BRCA2 (Chr 13; ER-positive female and male breast cancer, pancreatic and prostate cancer), TP53 (Li-Fraumeni), PTEN (Cowden syndrome), and CDH1 (E-cadherin: lobular breast and diffuse gastric cancer). Average-risk women undergo biennial screening mammography starting at age 40.
Histopathologically, breast neoplasms are divided into non-invasive in situ lesions (which do not penetrate the basement membrane and retain an outer myoepithelial cell layer) and invasive carcinomas, with every invasive specimen tested for Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2/neu (ERBB2) expression.
| Breast Carcinoma Subtype / Nerve | Pathognomonic Histopathology / Anatomy | Clinical & Mammographic Presentation | Receptor / Molecular Signature | Standard Surgical & Adjuvant Strategy |
|---|---|---|---|---|
| Ductal Carcinoma In Situ (DCIS) vs. LCIS | DCIS: Comedo necrosis + microcalcifications inside basement membrane | LCIS: Discohesive cells, loss of E-cadherin | DCIS: Clustered microcalcifications on mammogram | LCIS: Incidental biopsy finding (no mass or calcifications) | DCIS: Precursor to ipsilateral IDC | LCIS: Marker of bilateral breast cancer risk | DCIS: Lumpectomy + Radiation + Tamoxifen (if ER+) | LCIS: Observation + Tamoxifen/Raloxifene chemoprevention |
| Invasive Ductal (IDC) vs. Invasive Lobular (ILC) | IDC: Desmoplastic tubules/nests | ILC: Single-file rows ('Indian file') & signet-ring cells, NO E-cadherin | IDC: Firm fixed mass, spiculated on mammogram | ILC: Subtle thickening, often multicentric/bilateral | Test all specimens for ER, PR, and HER2/neu (FISH/IHC) | Lumpectomy + Radiation OR Mastectomy + Sentinel Lymph Node Biopsy; ER+ gets Tamoxifen (premenopausal) or Anastrozole (postmenopausal); HER2+ gets Trastuzumab |
| Paget Disease of the Breast | Intraepidermal malignant adenocarcinoma cells (Paget cells: PAS+, HER2+, S-100 negative) | Unilateral eczematous, crusted, weeping ulceration of the nipple and areola | Almost always (>95%) associated with underlying DCIS or Invasive Ductal Carcinoma | Full-thickness nipple wedge/punch biopsy + mammogram/MRI -> Central lumpectomy + radiation or mastectomy |
| Inflammatory Breast Cancer (T4d) | Invasive tumor emboli plugging dermal lymphatics | Erythema, warmth, and peau d'orange dermal edema covering >=1/3 of breast (mimics acute mastitis) | Frequently HER2-positive or triple-negative; high early metastatic rate | Neoadjuvant systemic chemotherapy FIRST -> Modified Radical Mastectomy -> Post-mastectomy chest wall radiation |
| Axillary Surgical Nerve Injuries | Long thoracic (Serratus anterior) | Thoracodorsal (Latissimus dorsi) | Intercostobrachial (T2 sensory) | Long thoracic: Winged scapula | Thoracodorsal: Weak arm adduction/extension | Intercostobrachial: Medial arm numbness | Iatrogenic traction or transection during axillary lymph node dissection | Prevent lymphedema by utilizing Sentinel Lymph Node Biopsy (SLNB) instead of full axillary dissection when nodes are negative |
Histologic Subtypes: DCIS, LCIS, Invasive Ductal, Invasive Lobular, Paget Disease & Inflammatory Breast Cancer
Ductal Carcinoma In Situ (DCIS) is a malignant proliferation of ductal epithelial cells confined within the basement membrane (no invasion into stroma), detected on mammography as clustered pleomorphic or linear branching microcalcifications (comedocarcinoma subtype shows central necrosis and dystrophic calcification); treatment is breast-conserving lumpectomy plus radiation (or mastectomy for diffuse multicentric disease) plus 5 years of tamoxifen/aromatase inhibitor if ER-positive. Lobular Carcinoma In Situ (LCIS) shows loss of E-cadherin with discohesive cells filling lobular acini without calcifications or a palpable mass; LCIS is treated not as a surgical malignancy itself, but as a bilateral marker of increased risk (20–30%) for future invasive ductal or lobular cancer in EITHER breast (managed with close surveillance and risk-reducing tamoxifen/raloxifene). Invasive Ductal Carcinoma (IDC) is the most common invasive breast cancer (75–80%), forming a rock-hard, stellate/spiculated desmoplastic mass on mammogram and biopsy. Invasive Lobular Carcinoma (ILC) (10%) lacks E-cadherin, infiltrating the stroma in single-file (“Indian file”) rows without desmoplasia, often presenting as vague thickening with a higher rate of bilateral/multifocal disease. Paget disease of the breast presents with unilateral eczematous, crusted, ulcerated, pruritic nipple scaling caused by intraepidermal extension of underlying DCIS or invasive ductal carcinoma (histology shows large pale Paget cells with clear halos in the epidermis; distinguish from benign nipple eczema, which is bilateral and spares the nipple apex). Inflammatory Breast Carcinoma (T4d) is the most aggressive subtype, caused by tumor emboli obstructing dermal lymphatics; patients present with rapid diffuse breast erythema, warmth, edema, and dimpled peau d'orange skin affecting ≥1/3 of the breast without a discrete mass (frequently misdiagnosed as mastitis in a non-lactating woman!), treated with neoadjuvant systemic chemotherapy first, followed by modified radical mastectomy and post-mastectomy radiation.
Breast-Conserving Therapy vs. Mastectomy, Sentinel Lymph Node Biopsy & Post-Axillary Nerve Lesions
For early-stage (Stage I–II) invasive breast cancer, Breast-Conserving Therapy (lumpectomy with negative margins PLUS whole-breast radiation therapy) provides equivalent overall survival to Mastectomy; absolute contraindications to lumpectomy/radiation include pregnancy, multicentric tumor in ≥2 quadrants, diffuse malignant microcalcifications, prior chest-wall radiation, and persistently positive margins (scleroderma/active SLE are relative contraindications). Clinically node-negative patients undergo Sentinel Lymph Node Biopsy (SLNB) using peritumoral technetium-99m sulfur colloid and isosulfan/methylene blue dye; complete axillary lymph node dissection (ALND) is reserved for clinically node-positive disease or multiple positive sentinel nodes. During axillary surgery or mastectomy, three classic nerves are at risk: (1) Long thoracic nerve (C5–C7) innervating the serratus anterior → injury causes medial winging of the scapula (when pushing against a wall) and inability to abduct the arm above 90 degrees; (2) Thoracodorsal nerve (C6–C8) innervating the latissimus dorsi → injury causes weakness of shoulder adduction, extension, and internal rotation; and (3) Intercostobrachial nerve (T2) → transection causes sensory numbness along the upper medial arm and axilla (while chronic lymphatic disruption causes ipsilateral upper-extremity lymphedema and, rarely, Stewart-Treves lymphangiosarcoma decades later).
Surgical Endocrinology: Thyroid Nodules, Parathyroidectomy & Adrenal/Pancreatic Incidentalomas
Surgical evaluation of a thyroid nodule begins with two simultaneous, mandatory steps: (1) Serum TSH measurement and (2) Thyroid & Cervical Lymph Node Ultrasound. If serum TSH is subnormal (suppressed), the next step is a Radionuclide Thyroid Scintigraphy Scan (I-123 or Tc-99m): a hyperfunctioning (“hot”) toxic adenoma carries a <1% malignancy risk and is treated with radioactive iodine ablation or lobectomy without biopsy, whereas a non-functioning (“cold”) nodule requires ultrasound-guided Fine-Needle Aspiration (FNA). If serum TSH is normal or elevated, do not order a radionuclide scan; proceed directly to ultrasound-guided FNA for any nodule ≥1.0 cm with suspicious sonographic features (hypoechogenicity, microcalcifications, taller-than-wide shape, irregular infiltrative margins, or suspicious cervical lymphadenopathy).
Across the four histological subtypes of thyroid carcinoma (Papillary, Follicular, Medullary, and Anaplastic), FNA cytology diagnoses all except Follicular Carcinoma, which cannot be distinguished from a benign follicular adenoma on FNA because malignancy is defined strictly by capsular or vascular invasion on surgical lobectomy histopathology.
| Endocrine Surgical Entity | Diagnostic Workup Sequence | Pathognomonic Pathology / Labs | Indications for Surgical Resection | Perioperative / Intraoperative Trap |
|---|---|---|---|---|
| Thyroid Nodule & Differentiated Cancer | Step 1: Serum TSH + Thyroid US -> Low TSH: I-123 scan | Normal/High TSH: FNA biopsy | Papillary: Orphan Annie nuclei, psammoma bodies (lymphatic) | Follicular: Capsular/vascular invasion (hematogenous) | Papillary/Follicular: Lobectomy or Total Thyroidectomy + I-131 ablation; follow serum Thyroglobulin for recurrence | FNA cannot distinguish Follicular Adenoma from Follicular Carcinoma (requires surgical lobectomy to check capsular/vascular invasion) |
| Medullary Thyroid Carcinoma (MEN 2A/2B) | FNA biopsy + Serum Calcitonin, CEA, RET gene testing, and Plasma Free Metanephrines | Parafollicular C-cell sheets in Calcitonin-derived Congo-red amyloid stroma | Total thyroidectomy with central neck lymph node dissection (prophylactic thyroidectomy in children with RET mutations) | ALWAYS rule out and resect a Pheochromocytoma (after alpha-blockade) BEFORE operating on Medullary Thyroid Cancer |
| Post-Thyroidectomy Stridor & Nerve Injury | Bedside inspection of neck incision and flexible laryngoscopy | Hematoma: Tense neck swelling | Bilateral RLN: Adducted vocal cords | Hypocalcemia: Chvostek/Trousseau | Expanding Hematoma: Cut open neck sutures AT THE BEDSIDE immediately before intubating | Superior laryngeal nerve (accompanies superior thyroid artery) -> pitch loss; Recurrent laryngeal nerve (inferior thyroid artery) -> hoarseness/stridor |
| Primary Hyperparathyroidism | High Ca2+, Low PO4, High/inappropriately normal PTH, 24-hr urine Ca2+ >200 mg (excludes FHH) | 85% Single Parathyroid Adenoma, 15% 4-gland Hyperplasia (MEN 1 / MEN 2A), <1% Carcinoma | Symptomatic (stones/bones) OR Asymptomatic meeting ANY: Age <50, Ca2+ >1.0 above ULN, T-score <=-2.5, GFR <60, Urine Ca >400 | Pre-op Tc-99m Sestamibi scan + neck US localizes the adenoma; confirm excision via >=50% drop in intraoperative PTH at 10 minutes |
| Adrenal Incidentaloma | All: 1-mg Dexamethasone test + Plasma Free Metanephrines | If HTN/Low K+: Aldosterone/Renin ratio | Benign adenoma: <10 Hounsfield units (lipid-rich) | Adrenocortical Ca: >4 cm, >10 HU, necrosis | Resect ANY functional tumor (Pheo, Aldosteronoma, Cortisol) OR any mass >=4 cm / malignant imaging features | NEVER biopsy an adrenal mass before ruling out Pheochromocytoma (needle biopsy of a pheo triggers fatal hypertensive crisis) |
Thyroid Cancer Subtypes, Post-Thyroidectomy Emergencies & Primary Hyperparathyroidism Surgery
Papillary thyroid carcinoma (85%; associated with childhood head/neck radiation and BRAF V600E or RET/PTC rearrangements) spreads via cervical lymphatics, exhibits Orphan Annie eye empty nuclei, nuclear grooves, and psammoma bodies, and carries an excellent (>95%) survival following thyroidectomy, TSH-suppressive levothyroxine, and radioactive iodine (I-131) ablation (monitored via serum thyroglobulin). Follicular thyroid carcinoma (10%; RAS mutation) spreads hematogenously to bone and lungs. Medullary thyroid carcinoma (4%; neural crest parafollicular C-cells secreting calcitonin into Congo-red-positive amyloid stroma; germline RET mutation in MEN 2A and MEN 2B) requires pre-operative screening for pheochromocytoma (plasma free metanephrines) before thyroidectomy so any pheochromocytoma can be resected first (after alpha-blockade). Anaplastic thyroid carcinoma (1%; TP53 mutation in elderly patients) presents as a rock-hard, rapidly enlarging neck mass causing tracheal compression and stridor. Following total thyroidectomy or parathyroidectomy, three acute neck emergencies occur: (1) Expanding cervical hematoma causing acute airway compression and stridor in the PACU → immediately cut open the skin and strap-muscle sutures at the bedside to evacuate the clot BEFORE attempting intubation; (2) Recurrent laryngeal nerve injury → unilateral injury causes hoarseness and a paramedian vocal cord, whereas bilateral injury causes acute vocal cord adduction, stridor, and asphyxiation requiring immediate intubation or tracheostomy (note: external branch of the superior laryngeal nerve injury causes loss of high-pitched voice projection in singers); and (3) Hypoparathyroidism / Hungry Bone Syndrome → perioral tingling, tetany, Chvostek/Trousseau signs, and QT prolongation within 24–48 hours (treat with IV calcium gluconate and calcitriol). In asymptomatic Primary Hyperparathyroidism (elevated Ca2+ and elevated/inappropriately normal PTH, 85% solitary adenoma), parathyroidectomy is indicated if ANY of the following criteria are met: Age <50 years, Serum Calcium >1.0 mg/dL above the upper limit of normal, DEXA T-score ≤-2.5 (osteoporosis) or vertebral fracture, eGFR <60 mL/min, Nephrolithiasis or 24-hour urine calcium >400 mg/day.
Adrenal Incidentaloma Workup & Pancreatic Neuroendocrine Tumors
An adrenal incidentaloma (≥1 cm mass discovered incidentally on abdominal CT) requires simultaneous evaluation for hormonal hypersecretion and malignant potential: (1) Screen all patients for pheochromocytoma (plasma free metanephrines or 24-hr urinary metanephrines) and autonomous cortisol secretion / Cushing syndrome (1-mg overnight dexamethasone suppression test); (2) If the patient is hypertensive or hypokalemic, also screen for primary aldosteronism (Conn syndrome) via the plasma aldosterone-to-renin ratio; and (3) If virilization or feminization is present, measure DHEA-S and sex steroids. Surgical adrenalectomy is indicated for any biochemically functional adrenal tumor (note: pheochromocytoma requires 10–14 days of irreversible/competitive alpha-adrenergic blockade [phenoxybenzamine or doxazosin] + high-sodium diet before adding a beta-blocker and proceeding to laparoscopy!) OR any non-functional mass that is ≥4 cm in diameter or shows suspicious malignant imaging features (>10 Hounsfield units on non-contrast CT, delayed contrast washout, necrosis, or local invasion indicative of adrenocortical carcinoma).
Cardiothoracic Surgery: Solitary Pulmonary Nodules, Mediastinal Masses (4 T's) & Esophageal Perforation
Surgical evaluation of a Solitary Pulmonary Nodule (SPN; a single well-circumscribed parenchymal lung lesion ≤3 cm surrounded by aerated lung without atelectasis, hilar adenopathy, or pleural effusion; lesions >3 cm are classified as lung masses and presumed malignant until proven otherwise) begins by comparing the current chest CT with prior chest imaging: a solid nodule that has remained completely stable in size for ≥2 years (or exhibits benign calcification patterns: diffuse, central, laminated/bull's-eye, or “popcorn” chondroid calcification of a pulmonary hamartoma) requires no further workup. For indeterminate solid nodules >8 mm, management is stratified by pretest malignancy probability (age, smoking pack-years, upper lobe location, spiculated/corona radiata margins): (1) Low probability (<5%) → serial surveillance low-dose CT at 3–6, 9–12, and 18–24 months; (2) Intermediate probability (5–65%) → functional imaging with FDG-PET/CT and/or CT-guided transthoracic core needle biopsy (for peripheral lesions) or navigational bronchoscopy / EBUS (for central lesions); and (3) High probability (>65%) → proceed directly to Video-Assisted Thoracoscopic Surgery (VATS) wedge resection with intraoperative frozen section followed immediately by anatomic lobectomy and mediastinal lymph node dissection if non-small cell lung cancer is confirmed (providing the patient has sufficient pulmonary reserve: predicted postoperative FEV1 >40% and DLCO >40%).
Mediastinal masses are anatomically compartmentalized into three surgical zones on lateral chest radiograph and chest CT: Anterior, Middle, and Posterior Mediastinum.
| Cardiothoracic Condition | Anatomic Location / Etiology | Pathognomonic Clinical / Imaging Findings | First-Line Diagnostic Modality | Definitive Surgical / Medical Management |
|---|---|---|---|---|
| Solitary Pulmonary Nodule (SPN <=3 cm) | Parenchymal lesion without adenopathy/atelectasis | Benign: Stable >=2 yr on old CXR/CT or popcorn calcification (hamartoma) | Malignant: >8 mm, upper lobe, spiculated | Compare with prior CT/CXR first; then FDG-PET/CT or CT-guided / EBUS biopsy | High risk (>65%): VATS wedge resection -> anatomic Lobectomy + mediastinal node dissection (requires PPO FEV1 & DLCO >40%) |
| Anterior Mediastinal Mass ('4 T's') | Thymoma, Teratoma (GCT), Terrible Lymphoma, Thoracic Thyroid | Thymoma: Fatigable ptosis/diplopia (Myasthenia Gravis) | GCT: Elevated AFP or beta-hCG in young male | Contrast Chest CT + Serum AFP, beta-hCG, and anti-AChR antibodies | Thymoma: Surgical Thymectomy | Lymphoma & Seminoma/NSGCT: Systemic Chemotherapy (avoid primary resection of lymphoma!) |
| Posterior Mediastinal Mass | Paravertebral sympathetic chain or intercostal nerve | Asymptomatic paraspinal mass on CXR; Horner syndrome or cord compression if intraspinal extension | MRI of Thoracic Spine & Chest (evaluates neural foraminal 'dumbbell' extension) | Surgical resection (Schwannoma/Neurofibroma in adults; Neuroblastoma in children) |
| Boerhaave Syndrome (Esophageal Perforation) | Transmural rupture of left posterolateral distal esophagus (or iatrogenic EGD) | Mackler triad (vomiting, chest pain, subcutaneous neck emphysema), Hamman crunch, Left effusion (pH <6.0, high amylase) | Water-Soluble Contrast Esophagram (Gastrografin) or CT Esophagram (NEVER barium first!) | NPO, IV Piperacillin-Tazobactam + Fluconazole, and Emergent Primary Surgical Repair (<24 hr) with tissue flap |
| Post-CABG Cardiac Tamponade | Mediastinal bleeding with clotted pericardial chest tube | Beck triad (hypotension, JVD, muffled heart sounds), pulsus paradoxus >10 mmHg, sudden drop in chest tube drainage | Bedside Transthoracic / Transesophageal Echocardiography (or immediate clinical diagnosis in arrest) | Emergent surgical re-exploration / resternotomy in OR (milk/strip chest tubes while preparing) |
Anterior, Middle & Posterior Mediastinal Masses (The '4 T's' vs. Neurogenic Tumors)
Anterior Mediastinal Masses (located between the sternum and the pericardium/great vessels) are remembered by the classic “4 T's”: (1) Thymoma (the most common primary anterior mediastinal neoplasm in adults aged 40–60; strongly associated with Myasthenia Gravis [30–50% of thymoma patients have anti-AChR antibodies], Pure Red Cell Aplasia, and hypogammaglobulinemia [Good syndrome]; treated with complete surgical thymectomy), (2) Teratoma / Germ Cell Tumor (calcified/cystic mass containing hair, teeth, or sebaceous tissue in young adults aged 15–35; check serum alpha-fetoprotein [AFP] and beta-hCG—elevated in nonseminomatous malignant germ cell tumors, which require cisplatin-based chemotherapy prior to resection), (3) Terrible Lymphoma (Hodgkin nodular sclerosis or T-cell lymphoblastic lymphoma presenting with B-symptoms and SVC syndrome; diagnosed via core needle or mediastinoscopic biopsy and treated with chemotherapy/radiation, NOT surgical resection!), and (4) Thoracic (Retrosternal) Thyroid Goiter. Middle Mediastinal Masses comprise congenital foregut cysts (bronchogenic cysts lined by respiratory epithelium and pericardial cysts at the right cardiophrenic angle), lymphadenopathy, and aortic arch aneurysms. Posterior Mediastinal Masses (located along the paravertebral gutters) are almost universally Neurogenic Tumors: Schwannomas and Neurofibromas in adults, and sympathetic chain Neuroblastoma, Ganglioneuroblastoma, or Ganglioneuroma in infants and children.
Esophageal Perforation (Boerhaave Syndrome) vs. Mallory-Weiss Tear & Post-CABG Tamponade
Forceful retching or vomiting against a closed glottis after heavy alcohol intake produces two distinct gastroesophageal emergencies: (1) Mallory-Weiss Syndrome is a partial-thickness mucosal/submucosal laceration at the gastroesophageal junction presenting with self-limited hematemesis without mediastinal air (managed supportively or with endoscopic epinephrine/clips); whereas (2) Boerhaave Syndrome is a full-thickness transmural esophageal rupture (most commonly at the left posterolateral distal esophagus 2–3 cm above the GE junction, though iatrogenic endoscopy/dilation is the #1 overall cause of esophageal perforation). Boerhaave syndrome presents with Mackler's triad (retching/vomiting, severe retrosternal/epigastric chest pain radiating to the back, and cervical subcutaneous emphysema), Hamman's crunch (mediastinal crepitus synchronous with the heartbeat), and a left pleural effusion containing high salivary amylase (>250 IU/L) and an acidic pH (<6.0). The initial diagnostic test of choice is a CT esophagram or contrast esophagram using water-soluble Gastrografin (because barium sulfate triggers severe granulomatous mediastinitis; if Gastrografin is negative but suspicion remains high, follow with thin barium to detect microperforations). Management requires immediate NPO, broad-spectrum IV antibiotics + antifungals, PPI, and emergent primary surgical repair within 24 hours (reinforced with an intercostal muscle or pleural flap). After cardiac surgery (CABG or valve replacement), sudden hypotension, rising central venous pressure (JVD), pulsus paradoxus, and sudden cessation of mediastinal chest tube output (due to a clotted chest tube) signify acute postoperative pericardial tamponade—requiring immediate return to the operating room for subxiphoid pericardiotomy / re-exploration.
Osteopathic Considerations in Post-Mastectomy Lymphedema, Thoracic Outlet Syndrome & Vascular Care
- In a patient presenting with Stanford Type A aortic dissection (involving the ascending aorta), proceed immediately to emergency open surgical repair; in Stanford Type B (descending aorta only), always administer an IV beta-blocker (esmolol or labetalol) FIRST before adding sodium nitroprusside or nicardipine to prevent reflex tachycardia and dissection propagation.
- When Acute Limb Ischemia (the 6 P's) is suspected, the VERY FIRST therapeutic step—before ordering CT angiography or transporting to the operating room—is an immediate intravenous bolus and infusion of unfractionated heparin.
- Never prescribe cilostazol (a PDE-3 inhibitor used for intermittent claudication in peripheral arterial disease) to a patient with congestive heart failure of any severity, as PDE-3 inhibitors increase mortality in heart failure.
- If a patient develops stridor and acute respiratory distress in the recovery room after a thyroidectomy or parathyroidectomy due to an expanding neck hematoma, DO NOT wait to intubate in the OR—immediately cut open the skin and strap-muscle sutures at the bedside to decompress the trachea.
- Never perform a fine-needle aspiration (FNA) or core biopsy of an adrenal mass before biochemically excluding Pheochromocytoma with plasma free metanephrines; biopsying an undiagnosed pheochromocytoma precipitates a lethal catecholamine crisis.
- A normal mammogram and normal breast ultrasound NEVER rule out breast cancer when a firm, suspicious palpable mass is present on clinical breast exam—always proceed to core needle biopsy.